► Customized research for ATHX vs. NVS!
► All in one page research, scroll down. Compare two other stocks.
► Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.
Done! Side by Side Research Below for ATHX vs. NVS.
↗ Join Our Free Email Newsletter.
► Athersys, Inc. vs. Novartis AG
Industry Match! Industry of Both ATHX and NVS:
Health Care/Life Sciences
ATHX
Data Last Updated: More than a wk ago
↻ Update Column 1 to Most Recent
► Key Statistics
Cap: 213.067M
P/E: N/A
P/S: 8.77
Q P/B: 7.89
Y Rev: 24.29M
Q Rev: (361,000)
Beta: 0.29

ATHX Share Stats
► Outstanding Shares
149.78M
► Float Shares
140.82M
► Percent of Float Short
8.74%
ATHX Insider Stats
► Percent Outstanding Insider Ownership
N/A
► Percent Outstanding Institution Ownership
N/A
ATHX Social Stats
► Followers
3
► B/S Rating Today
0
► B/S Rating All-Time
+1
Share ATHX Insights
ATHX Profile
► CEO
Dr. Gil van Bokkelen
► Exchange
Nasdaq
► Employees
75.00
► About
Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions...

ATHX Financials
Annual Financials
Income Statement
► Revenue
24.29M
► Net Income
(24.28M)
Cash Flow Statement
► Change in Cash / Investments
21.74M
Balance Sheet
► Cash / Investments
51.06M
► Short Term Debt
None
► Long Term Debt
None
► Total Current Assets
57.84M
► Total Current Liabilities
15.48M
► Total Assets
61.73M
► Total Liabilities
18.61M
► Stockholder Equity
43.12M
Quarterly Financials
Income Statement
► Q Revenue
(361,000)
► Q Net Income
(12.02M)
Cash Flow Statement
► Q Change in Cash / Investments
(3.79M)
Balance Sheet
► Q Cash / Investments
40.45M
► Q Short Term Debt
None
► Q Long Term Debt
None
► Q Total Current Assets
42.47M
► Q Total Current Liabilities
14.85M
► Q Total Assets
47.43M
► Q Total Liabilities
20.43M
► Q Stockholder Equity
27M

ATHX Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

NVS
Data Last Updated: 4 days ago
↻ Update Column 2 to Most Recent
► Key Statistics
Cap: 209.274B
P/E: 18.22
P/S: 4.12
Q P/B: 4
Y Rev: 50.79B
Q Rev: 12B
Beta: 0.51

NVS Share Stats
► Outstanding Shares
2.53B
► Float Shares
2.29B
► Percent of Float Short
0.11%
NVS Insider Stats
► Percent Outstanding Insider Ownership
0%
► Percent Outstanding Institution Ownership
13.07%
NVS Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share NVS Insights
NVS Profile
► CEO
Dr. Vasant Narasimhan
► Exchange
NYSE
► Employees
125,161
► About
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops,...

NVS Financials
Annual Financials
Income Statement
► Revenue
50.79B
► Net Income
12.34B
Cash Flow Statement
► Change in Cash / Investments
4.32B
Balance Sheet
► Cash / Investments
15.73B
► Short Term Debt
6.34B
► Long Term Debt
22.06B
► Total Current Assets
35.06B
► Total Current Liabilities
29.19B
► Total Assets
143.58B
► Total Liabilities
66B
► Stockholder Equity
77.5B
Quarterly Financials
Income Statement
► Q Revenue
12B
► Q Net Income
2.01B
Cash Flow Statement
► Q Change in Cash / Investments
(1.59B)
Balance Sheet
► Q Cash / Investments
8.69B
► Q Short Term Debt
7.99B
► Q Long Term Debt
20.07B
► Q Total Current Assets
26.6B
► Q Total Current Liabilities
28.14B
► Q Total Assets
115.64B
► Q Total Liabilities
63.19B
► Q Stockholder Equity
52.37B

NVS Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

